RXcelebs
 
877-RX-CELEBS info@rxcelebs.com REQUEST MORE INFO
   
HOME WHO WE ARE WHAT MAKES US UNIQUE OUR SERVICES OUR CLIENTS OUR WORK INDUSTRY NEWS
 
CONTACT US
 
Home > NewsIndustry News > Healthcare Updates
  Medical Marketing & Media
Changes at the top of commercial units for Gilead and BMS
Wed, 29 Aug 2018 15:00:45 GMT
Christopher Boerner was promoted to lead commercial at BMS, and Laura Hamill joined Gilead from Amgen to head up its commercial operations.
Five things for pharma marketers to know: Wednesday, August 29, 2018
Wed, 29 Aug 2018 14:10:01 GMT
Gilead appoints new commercial lead; U.K. bans online ad for contraception app; Pfizer petitions the FDA to clarify biosimilar communications.
'If WPP's next CEO isn't Mark Read, it's got to be a spectacular choice,' analysts say
Wed, 29 Aug 2018 11:00:00 GMT
Some of the advertising industry's top analysts say Mark Read looks the best choice to be WPP's chief executive and the board would need to find a "spectacular" alternative.
After failure of generic fish oil trial, some caution against read-across to Vascepa study
Wed, 29 Aug 2018 11:00:00 GMT
Amarin's Vascepa trial is set to read out results by the end of September.
Five things for pharma marketers to know: Tuesday, August 28, 2018
Tue, 28 Aug 2018 14:21:24 GMT
Gilead's CAR-T cell therapy ruled too expensive in the U.K.; Experts mixed on impact of drug price hike freezes; Women turn to wearables for fertility tracking
Experts split on impact of drug price hike freezes
Tue, 28 Aug 2018 11:00:00 GMT
Some of the world's most powerful pharmaceutical companies backed down on planned price increases following a new transparency law in California and social media hectoring from President Donald Trump.
Five things for pharma marketers to know: Monday, August 27, 2018
Mon, 27 Aug 2018 14:13:16 GMT
Pfizer's drug tafamidis reduces risk of death; Lilly Diabetes pulls its sponsorship of Daly's car; FDA investigates electronic cigarette maker Juul.
The highs and lows of cannabis branding
Mon, 27 Aug 2018 13:51:05 GMT
Chase Design Group's John Tanner shares what he thinks brands can do to spice things up when it comes to marketing around marijuana.
Got name? A peek into the sometimes bizarre land of pharma brand-naming
Mon, 27 Aug 2018 11:00:00 GMT
As more medications are approved, pharma companies are being pushed farther afield into a land of bizarre — but hopefully still memorable and vaguely meaningful — drug names.
Five things for pharma marketers to know: Friday, August 24, 2018
Fri, 24 Aug 2018 14:19:09 GMT
White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire's potential blockbuster HAE treatment.
Behind the Exact Sciences/Pfizer Cologuard co-promotion deal
Fri, 24 Aug 2018 13:51:22 GMT
The companies plan to make the most of favorable market access conditions for the at-home colon cancer screening test.
Pfizer lawsuit could clear path for biosimilars
Thu, 23 Aug 2018 17:00:00 GMT
Biosimilars have only been in the market for three years, but they have struggled to compete with their branded equivalents.
Read the August 2018 Digital Ediiton
Thu, 23 Aug 2018 14:49:10 GMT
Five things for pharma marketers to know: Thursday, August 23, 2018
Thu, 23 Aug 2018 13:50:41 GMT
Trump's conflicting policies on PBMs confuse the industry; Pfizer strikes deal to co-promote Cologuard; Tech company develops microchip for dementia patients.
Five things for pharma marketers to know: Wednesday, August 21, 2018
Wed, 22 Aug 2018 14:16:13 GMT
FDA extends EpiPen expiration dates; GE Ventures senior managing director departs; Facebook launches MRI research project.
 
 
© 2009 Rx Celebs, LLC